Jill Breaux
Primary Care · Jennings, LANPI 1598019978
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 41.8% of the total.
Across 161 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$274
- GSK$150
- AstraZeneca$116
- Ardelyx, Inc.$116
- Alkermes, Inc.$90
- plus $758 from 16 others
What the payments were for
- Food & beverage$2,583100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,079 |
| Lilly USA, LLC | 13 | $274 |
| GSK | 3 | $150 |
| AstraZeneca | 8 | $116 |
| Ardelyx, Inc. | 5 | $116 |
| Alkermes, Inc. | 4 | $90 |
| Supernus Pharmaceuticals, Inc. | 4 | $80 |
| Pfizer | 4 | $76 |
| Novartis | 5 | $72 |
| Novo Nordisk | 4 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $67 |
| Abbott | 4 | $62 |
| Amgen | 4 | $60 |
| Merck | 3 | $46 |
| Indivior Inc. | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $36 |
| Exact Sciences | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$113
How this compares
$2,583 in reported general payments places this provider in the 80th percentile of 106 primary care providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 60 | $76,675 |
| MounjaroTirzepatide | 56 | $70,453 |
| JardianceEmpagliflozin | 39 | $36,710 |
| FarxigaDapagliflozin Propanediol | 33 | $32,684 |
| TrulicityDulaglutide | 16 | $22,533 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $20,610 |
| RexultiBrexpiprazole | 13 | $18,769 |
| LinzessLinaclotide | 24 | $18,100 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,656 |
| Emgality PenGalcanezumab-Gnlm | 11 | $6,933 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $6,462 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $3,304 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 62 | $2,493 |
| SynthroidLevothyroxine Sodium | 11 | $1,389 |
| Scopolamine | 18 | $1,290 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $274 | $92,98772 claims |
| Novo NordiskOzempic | $69 | $76,67560 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $116 | $45,64459 claims |
| GSKTrelegy Ellipta | $150 | $20,61026 claims |
| AbbVieLinzess, Synthroid | $1,079 | $19,48935 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $28 | $18,76913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 106 primary care providers in Louisiana.
Other primary care in Jennings
- Wendy TaylorShreveport$15K
- Jodi BurasCovington$14K
- Mia Schexnayder-DavisNew Orleans$10K
- Lourdes TorresMonroe$8K
- Danielle WebsterPrairieville$8K
- Alle NorrisCovington$6K
- Ariel GrahamRayville$6K
- Eleisa FloydHouma$6K
- Emily FusilierBaton Rouge$5K
- Angela ParettiCovington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.